Why the study?
Is severe renal insufficiency (eGFR ≤ 45.0) associated with increased mortality in patients treated with an implantable cardioverter defibrillator?
Is severe renal insufficiency (eGFR ≤ 45.0) associated with increased mortality in patients treated with an implantable cardioverter defibrillator?
Answers are grounded in this paper and cite their sources.
Patients with an eGFR ≤ 45.0 mL/min/1.73 m² treated with an ICD have significantly shorter survival times, suggesting that severe renal insufficiency should be considered during patient selection for ICD therapy.
OBJECTIVES: We explored the association between renal insufficiency (RI) and mortality among patients treated with an implantable cardioverter defibrillator (ICD). BACKGROUND: Randomized trials have shown improvements in survival among select patients treated with an ICD. Renal insufficiency patients have a high risk of cardiac death; however, it is not clear whether the ICD has a positive effect on survival in this group of patients. METHODS: This was a retrospective review of a single-center experience of 346 patients treated with an ICD. Patients were stratified into 4 groups according to their glomerular filtration rate (eGFR; expressed as mL/min/ -1.73 m(2)) at implantation: group I, > 75.0; group II, - 60.0 to 74.9; group III, - 45.0 to 59.9; and group IV, - < or = 45.0. All-cause mortality was the primary end point, with differences in survival times among the 4 groups of patients expressed in Kaplan-Meier curves. RESULTS: Mean follow-up was 3.5 y (range 0.1 to 12.9 y), during which 67 patients died (19%). Mortality in each eGFR group was: I - 6.8%, II - 13.8%, III - 11.5%, IV - 45.8% (p < 0.001). Survival times (mean, y) were I, 3.74; II, 3.66; III, 3.38, and IV, 2.82. The presence of diabetes was not a factor in the outcomes. CONCLUSIONS: Patients treated with an ICD with an eGFR of < or = 45.0 mL/min/1.73 m(2) have a significantly shorter survival time than those patients with an eGFR > 45.0 mL/min/1.73 m(2). Patients with an eGFR > 45.0 mL/min/1.73 m(2) appear to have equally good outcomes when treated with an ICD. This may have implications for patient selection for ICD therapy.
No takes yet. Share an insight, caveat, or question.
Levy et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: